Founded in 2018, HaystackAnalytics operates in Health Tech offering state-of-the-art genomics technology for personalised clinical decisions. The company specialises in providing scalable, affordable,...
Funding stage:
Undisclosed
Last funding:
07/04/2021
Investors
Employee count:
308
Last 90d
308
Last 90d
Web traffic:
2.4K
2.4K
Last 30d
Last 30d
HaystackAnalytics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders20
Latest Filing Date25 Feb 2026- Funding Events25
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of HaystackAnalytics
As of 26 February 2026, HaystackAnalytics's equity is held by 20 shareholders, with the top three being Anirvan Chatterjee, Gaurav Srivastava, and Alkem Laboratories Limited.
Anirvan Chatterjee holds the largest stake in HaystackAnalytics at 23.0% as of 26 February 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links